Rockwell Medical (RMTI) Net Equity Issued and Repurchased (2010 - 2025)

Rockwell Medical's Net Equity Issued and Repurchased history runs 11 years deep, the most recent figure standing at $7.8 million for Q3 2025.

• Quarterly Net Equity Issued and Repurchased rose 114.88% year-over-year to $7.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (down 23.39% YoY) and the FY2025 annual result came in at $7.8 million, down 23.23% from the prior year.
• Net Equity Issued and Repurchased was $7.8 million for Q3 2025 at Rockwell Medical, up from $3.8 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $13.8 million in Q3 2023 and bottomed at $560000.0 in Q1 2024.
• A 3-year average of $4.7 million and a median of $3.6 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
• Peak annual rise in Net Equity Issued and Repurchased reached 244.99% in 2024, while the deepest fall reached 73.62% in 2024.
• Rockwell Medical's Net Equity Issued and Repurchased stood at $1.1 million in 2023, then surged by 244.99% to $3.8 million in 2024, then soared by 105.91% to $7.8 million in 2025.
• Business Quant data shows RMTI's Net Equity Issued and Repurchased at $7.8 million in Q3 2025, $3.8 million in Q4 2024, and $3.6 million in Q3 2024.